Post-translational modifications on RNA-binding proteins: accelerators, brakes, or passengers in neurodegeneration?

This publication has 140 references indexed in Scilit:

• Redox signalling directly regulates TDP‐43 via cysteine oxidation and disulphide cross‐linking
  The EMBO Journal, 2011
• Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia
  Nature, 2011
• FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations
  Brain, 2011
• Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
  Nature Neuroscience, 2011
• ALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import
  The EMBO Journal, 2010
• A new subtype of frontotemporal lobar degeneration with FUS pathology
  Brain, 2009
• Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity
  Proceedings of the National Academy of Sciences, 2009
• Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies
  Journal of Biological Chemistry, 2009
• Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies
  Acta Neuropathologica, 2009
• Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
  Annals of Neurology, 2008